中国生物制药 (01177.HK)

+ 收藏

资产负债表(中国生物制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报
截止日期 2023-12-312023-06-302022-12-312022-06-30
报表类型 合并报表合并报表合并报表合并报表
报表年结日 1231123112311231
上市前/上市后 上市后上市后上市后上市后
原始币种 人民币人民币人民币人民币
流动资产
 现金及现金等价物(元) 9,451,878,000.0011,577,189,000.0012,066,217,000.007,768,292,000.00
 以公允价值计量且其变动计入当期损益的金融资产流动(元) 3,113,040,000.003,939,076,000.004,855,446,000.007,906,536,000.00
 应收账款及票据(元) 4,510,195,000.007,108,970,000.004,638,396,000.004,947,839,000.00
 应收关连公司款项(元) 188,610,000.0079,886,000.00382,742,000.00406,921,000.00
 预付款项、按金及其他应收款项流动(元) 3,635,630,000.002,093,515,000.001,663,260,000.002,031,041,000.00
 存货(元) 1,993,472,000.002,018,498,000.002,328,844,000.002,137,132,000.00
 流动资产其他项目(元) 912,706,000.00160,135,000.00--
 流动资产合计(元) 23,805,531,000.0026,977,269,000.0025,934,905,000.0025,197,761,000.00
非流动资产
 物业、厂房及设备(元) 8,080,907,000.007,897,904,000.007,759,592,000.007,394,940,000.00
 投资物业(元) 289,342,000.00713,651,000.00720,754,000.00733,218,000.00
 预付款项、按金及其他应收款项非流动(元) 302,673,000.00651,783,000.00508,261,000.00525,210,000.00
 商誉及无形资产(元) 2,908,961,000.002,941,691,000.001,914,450,000.001,856,621,000.00
  其中:商誉(元) 680,452,000.00812,083,000.00662,611,000.00642,552,000.00
    无形资产(元) 2,228,509,000.002,129,608,000.001,251,839,000.001,214,069,000.00
 于联营和合营公司投资(元) 12,243,675,000.0013,083,084,000.0013,198,157,000.0014,814,226,000.00
 以公允价值计量且其变动计入当期损益的金融资产非流动(元) 6,262,573,000.006,955,255,000.005,679,426,000.005,778,638,000.00
 递延税项资产(元) 567,012,000.00508,906,000.00505,148,000.00414,310,000.00
 非流动资产其他项目(元) 9,144,145,000.005,911,344,000.007,843,591,000.008,219,536,000.00
 非流动资产合计(元) 39,799,288,000.0038,663,618,000.0038,129,379,000.0039,736,699,000.00
资产总额(元) 63,604,819,000.0065,640,887,000.0064,064,284,000.0064,934,460,000.00
流动负债
 短期借款(元) 11,135,940,000.0010,484,951,000.006,217,153,000.004,068,753,000.00
 融资租赁负债流动(元) 71,488,000.0037,789,000.0060,431,000.0049,451,000.00
 衍生金融负债流动(元) --146,321,000.00117,363,000.00
 应付账款及票据(元) 1,334,703,000.002,137,213,000.001,637,351,000.002,676,473,000.00
 其他应付款项及应计费用(元) 9,405,589,000.0013,981,167,000.008,153,130,000.008,828,608,000.00
 应付税项(元) 271,871,000.00178,077,000.00107,455,000.00100,151,000.00
 流动负债其他项目(元) 251,054,000.0015,264,000.003,446,257,000.00-
 流动负债合计(元) 22,606,775,000.0026,865,415,000.0020,150,677,000.0016,265,507,000.00
 流动资产净值(元) 1,198,756,000.00111,854,000.005,784,228,000.008,932,254,000.00
 总资产减流动负债(元) 40,998,044,000.0038,775,472,000.0043,913,607,000.0048,668,953,000.00
非流动负债
 长期借款(元) 1,057,944,000.00685,632,000.003,933,859,000.004,313,157,000.00
 融资租赁负债非流动(元) 298,394,000.00329,246,000.00324,263,000.00356,177,000.00
 递延税项负债(元) 781,543,000.00623,447,000.00831,791,000.001,025,561,000.00
 递延收入非流动(元) 548,272,000.00525,684,000.00749,070,000.00694,739,000.00
 非流动负债其他项目(元) 141,938,000.00152,658,000.00131,076,000.003,534,709,000.00
 非流动负债合计(元) 2,828,091,000.002,316,667,000.005,970,059,000.009,924,343,000.00
负债总额(元) 25,434,866,000.0029,182,082,000.0026,120,736,000.0026,189,850,000.00
股东权益
 股本(元) 414,615,000.00414,615,000.00414,899,000.00414,942,000.00
 储备(元) 31,829,577,000.0031,201,453,000.0030,764,620,000.0031,177,810,000.00
  其他储备(元) 31,829,577,000.0031,201,453,000.0030,764,620,000.0031,177,810,000.00
 归属于母公司股东权益其他项目(元) -1,769,723,000.00-1,626,773,000.00-1,432,484,000.00-1,378,597,000.00
 归属于母公司股东权益(元) 30,474,469,000.0029,989,295,000.0029,747,035,000.0030,214,155,000.00
 非控股权益(元) 7,695,484,000.006,469,510,000.008,196,513,000.008,530,455,000.00
 股东权益合计(元) 38,169,953,000.0036,458,805,000.0037,943,548,000.0038,744,610,000.00
负债及股东权益合计(元) 63,604,819,000.0065,640,887,000.0064,064,284,000.0064,934,460,000.00
公告日期 2024-03-282023-09-262023-04-282022-09-26
会计准则 香港会计准则香港会计准则香港会计准则香港会计准则
审计意见 ----
核数师 ----
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院